Stories
Anthropic's Claude AI Discovers Novel Enzyme System, Revolutionizing Gene Editing Potential
N
News18•24-09-2026, 07:00
Anthropic's Claude AI Discovers Novel Enzyme System, Revolutionizing Gene Editing Potential
- •Anthropic's AI system Claude has made a biomedical breakthrough by discovering a previously unknown enzyme system in bacteriophage DNA, potentially representing a new gene editing mechanism.
- •The newly discovered system features a reverse transcriptase (RT) enzyme and an associated array of non-coding DNA sequences, bearing similarities to CRISPR technology.
- •While the underlying RT was previously identified, Claude is the first to recognize the system's defining features, suggesting its potential for cutting, copying, and pasting DNA.
- •Anthropic CEO Dario Amodei highlights AI's accelerating role in biology, with Claude proposing experiments to verify its discoveries and potentially autonomously controlling lab equipment in the future.
- •This discovery could significantly advance understanding of biology, lead to new therapeutic modalities, and demonstrates the value of AI-driven hypothesis generation in scientific research.
Key Questions Answered
Anthropic announced that its AI system Claude discovered a previously unknown enzyme system hidden in the DNA of bacteriophages, which could represent a new gene editing mechanism.
The newly found system is based on a reverse transcriptase and features an associated array of non-coding DNA sequences alongside an additional accessory protein of unknown function, sharing structural similarities to CRISPR arrays.
CEO Dario Amodei explained that after the life sciences team suggested a broad research area, Claude read through literature and genome data, uncovered the system, and proposed experiments for human verification.
